Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Specialty Compounding for Improved Patient Care: 2006 National Survey of Compounding Pharmacists

Author(s):  Huffman DC, Holmes Erin R

Issue:  Jan/Feb 2008 - Compounding for Hospice and Cancer Patients
View All Articles in Issue

Page(s):  74-82

Specialty Compounding for Improved Patient Care: 2006 National Survey of Compounding Pharmacists Page 1
Specialty Compounding for Improved Patient Care: 2006 National Survey of Compounding Pharmacists Page 2
Specialty Compounding for Improved Patient Care: 2006 National Survey of Compounding Pharmacists Page 3
Specialty Compounding for Improved Patient Care: 2006 National Survey of Compounding Pharmacists Page 4
Specialty Compounding for Improved Patient Care: 2006 National Survey of Compounding Pharmacists Page 5
Specialty Compounding for Improved Patient Care: 2006 National Survey of Compounding Pharmacists Page 6
Specialty Compounding for Improved Patient Care: 2006 National Survey of Compounding Pharmacists Page 7
Specialty Compounding for Improved Patient Care: 2006 National Survey of Compounding Pharmacists Page 8
Specialty Compounding for Improved Patient Care: 2006 National Survey of Compounding Pharmacists Page 9

Download in electronic PDF format for $75

Abstract:  Pharmacy compounding is re-emerging as a critical area of pharmacy practice. This re-emergence has generated considerable discussion among stakeholders of the pharmacy profession about how pharmacy compounding is best regulated to ensure the safety and efficacy of compounded preparations. In light of this discussion, the American College of Apothecaries conducted a survey in August 2006 that was sent to compounding pharmacists, the list of which was provided by the International Journal of Pharmaceutical Compounding. The purpose of the survey was to (1) assess the safety and efficacy of compounded preparations as reported by compounding pharmacists, (2) describe the types of compounding and other professional services that are offered by these pharmacists, (3) describe selected business information for compounding pharmacies, and (4) monitor changes in the compounding pharmacy landscape since the 2005 National Survey of Compounding Pharmacists, the results of which were published in the November/December 2006

Related Keywords: drug safety, compounding pharmacist survey, instability, quality control, adverse effects, pharmacy services, specialty services, regulations, legislation, U.S. Food and Drug Administration, Pharmacy Compounding Accreditation Board, American College of Apothecaries, drug stability

Related Categories: BUSINESS, LEGAL, PEER-REVIEWED, ADVERSE DRUG EVENTS, PROFESSIONAL ISSUES

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Specialty Compounding for Improved Patient Care: 2006 National Survey of Compounding Pharmacists
Huffman DC
, Holmes Erin R
Jan/Feb 2008
Pg. 74-82

Specialty Compounding for Improved Patient Care: A National Survey of Compounding Pharmacists
Huffman DC
, Holmes Erin R
Nov/Dec 2006
Pg. 462-468

Patient-centered Care as Value-added Service by Compounding Pharmacists
McPherson Timothy B
, Fontane Patrick E, Day Jonathan R
Jul/Aug 2013
Pg. 339-343

Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 181-185

Applying Quality of Design Concepts to Pharmacy Compounding
Timko Robert J
Nov/Dec 2015
Pg. 453-463

The U.S. Food and Drug Administration Responds to the International Academy of Compounding Pharmacists' Outsourcing Letter
Miller David G
May/Jun 2014
Pg. 208

Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Allen Loyd V Jr
Jul/Aug 2016
Pg. 351

View Sample
U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies
Yoch Doug
Mar/Apr 2017
Pg. 95-102

PostScription: Pharmacy Benefit Managers and Compounding Pharmacists: Billing for Services
Lees Deril J
Jan/Feb 2014
Pg. 87

Pharmacists' Perceptions of the Economic Value of Compounded Pharmaceuticals: A Comparison of Compounded and Commercial Pharmaceuticals in Select Disease States
Lobb William B
, Wilkin Noel E, Holmes Erin R
Nov/Dec 2015
Pg. 514-520

Compounding Pharmacy: A Unique Service for a Unique Population
Williams LaVonn A
, Franck Paul
Jan/Feb 2010
Pg. 19-20

PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Allen Loyd V Jr
Sep/Oct 2017
Pg. 356

Finally: A Final U.S. Food and Drug Administration Memorandum of Understanding, but It's Flawed
Brunner Scott
Jul/Aug 2020
Pg. 296-297

Incorporating Quality Assurance in Pharmaceutical Compounding-related Courses in the PharmD Curricula
Hossain Mohammad Faisal
, Levesque Dan, Frye John, Rashid Mamoon
Jul/Aug 2020
Pg. 322-326

U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs
Allen Loyd V Jr
Nov/Dec 2015
Pg. 487-488

U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances
Miller David G
Jul/Aug 2015
Pg. 303-305

Pharmaceutical Compounding: The Oldest, Most Symbolic, and Still Vital Part of Pharmacy
Kochanowska-Karamyan Anna J
Sep/Oct 2016
Pg. 367-374

Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1
Martin Matt
Sep/Oct 2018
Pg. 401-404

The International Academy of Compounding Pharmacists Comments to the Draft Memorandum of Understanding
Miller David G
Sep/Oct 2015
Pg. 375

Safety Standards in Pharmaceutical Compounding, Part 3: Fire Safety
Allen W Chris
, Greeson Nicole MH, Mixon William
Nov/Dec 2020
Pg. 451-458

Return to Top